Breast Cancer Trial, Recruiting NCT06461650 Sponsor: University of Florida Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06461650
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 to 80 years old
  • Women who have been diagnosed with Stage 0 to Stage 3 breast cancer, confirmed by biopsy
  • Women whose surgical team has recommended breast reconstruction at the time of mastectomy, or oncoplastic surgery at the time of lumpectomy (a procedure to reshape the breast after tumour removal)
  • People who currently use nicotine products of any kind and have reported using them within the past month
  • People who are willing to follow all study-related procedures and requirements

Who may not be able to join:

  • People whose surgeon has determined they are not suitable for reconstruction or oncoplastic surgery for reasons such as a BMI over 35, a diagnosis of inflammatory breast cancer, or other clinical concerns at the surgeon's discretion
  • People who are currently imprisoned, involuntarily incarcerated, or held under a legal order for treatment of a psychiatric or physical illness
  • People who are unable to complete the study sessions due to language, travel, or technology barriers
  • People who are already taking part in another nicotine or smoking cessation program
  • People who are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Christiana Shaw, MD, University of Florida

Phone: (352) 273-8429

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
14 November 2024
Est. completion
1 March 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov